Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

NovaBridge Biosciences (NBP) Current Assets (2018 - 2022)

NovaBridge Biosciences (NBP) has disclosed Current Assets for 5 consecutive years, with $509.9 million as the latest value for Q4 2022.

  • Quarterly Current Assets fell 31.82% to $509.9 million in Q4 2022 from the year-ago period, while the trailing twelve-month figure was $509.9 million through Dec 2022, down 31.82% year-over-year, with the annual reading at $525.8 million for FY2022, 29.93% down from the prior year.
  • Current Assets for Q4 2022 was $509.9 million at NovaBridge Biosciences, down from $747.9 million in the prior quarter.
  • The five-year high for Current Assets was $806.3 million in Q4 2020, with the low at $193.1 million in Q4 2019.
  • Average Current Assets over 5 years is $510.4 million, with a median of $509.9 million recorded in 2022.
  • The sharpest move saw Current Assets crashed 34.44% in 2019, then surged 317.47% in 2020.
  • Over 5 years, Current Assets stood at $294.6 million in 2018, then plummeted by 34.44% to $193.1 million in 2019, then surged by 317.47% to $806.3 million in 2020, then dropped by 7.24% to $747.9 million in 2021, then crashed by 31.82% to $509.9 million in 2022.
  • According to Business Quant data, Current Assets over the past three periods came in at $509.9 million, $747.9 million, and $806.3 million for Q4 2022, Q4 2021, and Q4 2020 respectively.